B. Bock-Hennig

发表

Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells.

K. Bock, P. Münzel, S. Schmohl, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Density-dependent growth of normal and nodular hepatocytes.

H. Gschaidmeier, K. Bock, B. Bock-Hennig, 2000, Toxicology.

UDP-glucuronosyltransferases (UGTs): from purification of Ah-receptor–inducible UGT1A6 to coordinate regulation of subsets of CYPs, UGTs, and ABC transporters by nuclear receptors

K. Bock, B. Bock-Hennig, 2010, Drug metabolism reviews.

Tissue-specific regulation of canine intestinal and hepatic phenol and morphine UDP-glucuronosyltransferases by beta-naphthoflavone in comparison with humans.

M. Eichelbaum, B. Burchell, K. Bock, 2002, Biochemical pharmacology.

AH receptor-controlled transcriptional regulation and function of rat and human UDP-glucuronosyltransferase isoforms.

H. Gschaidmeier, K. Bock, H. Heel, 1998, Advances in enzyme regulation.

Growth modulation of hepatocytes and rat liver epithelial cells (WB-F344) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

H. Gschaidmeier, K. Bock, B. Bock-Hennig, 1996, Carcinogenesis.

Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases.

H. Gschaidmeier, K. Bock, H. Heel, 1999, Drug metabolism reviews.

The role of conjugation reactions in detoxication

K. Bock, B. Bock-Hennig, W. Lilienblum, 2004, Archives of Toxicology.

Induction and inhibition of conjugating enzymes with emphasis on UDP-glucuronyltransferases.

K. Bock, B. Bock-Hennig, W. Lilienblum, 1987, Pharmacology & therapeutics.

UDP-glucuronyltransferases and their toxicological significance.

K. Bock, B. Bock-Hennig, W. Lilienblum, 1986, Advances in experimental medicine and biology.

Induction of drug-metabolizing enzymes by xenobiotics.

H. Lipp, K. Bock, B. Bock-Hennig, 1990, Xenobiotica; the fate of foreign compounds in biological systems.

Release of mutagenic metabolites of benzo[a]pyrene from the perfused rat liver after inhibition of glucuronidation and sulfation by salicylamide.

K. Bock, B. Bock-Hennig, W. Lilienblum, 1981, Chemico-biological interactions.

Differential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers.

K. Bock, B. Bock-Hennig, K W Bock, 1987, Biochemical pharmacology.

Roles of UDP-glucuronosyltransferase in the inactivation of benzo(a)pyrene.

K. Bock, B. Bock-Hennig, W. Lilienblum, 1981, Advances in experimental medicine and biology.

Serotonin glucuronidation by Ah receptor- and oxidative stress-inducible human UDP-glucuronosyltransferase (UGT) 1A6 in Caco-2 cells.

K. Bock, B. Bock-Hennig, O. Badary, 2005, Biochemical pharmacology.

Influence of t-butylhydroquinone and beta-naphthoflavone on formation and transport of 4-methylumbelliferone glucuronide in Caco-2/TC-7 cell monolayers.

K. Bock, B. Bock-Hennig, K. Nill, 2002, Biochemical pharmacology.

Activating and inactivating reactions controlling 2-naphthylamine mutagenicity

K. Bock, B. Bock-Hennig, D. Ullrich, 1982, Archives of Toxicology.

Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferase of the UGT1 gene complex.

D. Schrenk, K. Bock, B. Bock-Hennig, 1994, Carcinogenesis.

Conditional expression of a constitutively active aryl hydrocarbon receptor in MCF-7 human breast cancer cells.

L. Poellinger, B. Bock-Hennig, C. Koehle, 2002, Archives of biochemistry and biophysics.

Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide.

K. Bock, B. Bock-Hennig, W. Lilienblum, 1985, Molecular pharmacology.